Abdulrafeh Naqash to Protein Kinase Inhibitors
This is a "connection" page, showing publications Abdulrafeh Naqash has written about Protein Kinase Inhibitors.
Connection Strength
0.588
-
Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series. J Immunother Cancer. 2019 01 08; 7(1):4.
Score: 0.588